Abstract:Stereoselective halogenation is a highly useful organic transformation for multistep syntheses because the resulting chiral organohalides can serve as precursors for various medicinally relevant derivatives. Even though decarboxylative halogenation of aliphatic carboxylic acids is a useful and fundamental synthetic method for the preparation of a variety of organohalides, an enantioselective version of this reaction has not been reported. Here we report a highly enantioselective decarboxylative chlorination of… Show more
“…[8,9] Scheme 1. [13] This investigation began with the phenol 1 a as a model substrate (Scheme 2, see SI for full-details). We recently introduced disubstituted Meldrum's acid (MA) derivatives as stable alternatives to hemimalonic esters for the enantioselective decarboxylative protonation reaction upon phase-transfer catalytic conditions, [10] while this architecture also affords new synthetic opportunities in heterocycle formation.…”
mentioning
confidence: 99%
“…At the onset, we considered the beautiful and unprecedented enantioselective decarboxylative chlorination reaction recently reported by Shibatomi et al [13], [20] This strategy applied to our domino cyclization-decarboxylative process would provide an unprecedented entry to dihydrocouramins 6 having a C3chlorinated tetrasubstituted stereocenter (Scheme 7). At the onset, we considered the beautiful and unprecedented enantioselective decarboxylative chlorination reaction recently reported by Shibatomi et al [13], [20] This strategy applied to our domino cyclization-decarboxylative process would provide an unprecedented entry to dihydrocouramins 6 having a C3chlorinated tetrasubstituted stereocenter (Scheme 7).…”
mentioning
confidence: 99%
“…Furthermore, by means of these MA-based platforms, a proof of concept of a sparingly reported asymmetric decarboxylative chlorination reaction was demonstrated allowing the construction of chiral C3-chlorinated dihydrocoumarins. [13] This investigation began with the phenol 1 a as a model substrate (Scheme 2, see SI for full-details). A screening of an array of chiral Brønsted bases revealed that quinine 3 a achieved the domino transformation into the desired 2 a in smooth conditions (rt, 2 hours), in a complete conversion and promising 37.5:62.5 er.…”
mentioning
confidence: 99%
“…Next, we wondered whether it could be possible to take advantage of the reactivity of the readily available Meldrum's acid platforms 4, for the construction of more substituted dihydrocoumarin derivatives. At the onset, we considered the beautiful and unprecedented enantioselective decarboxylative chlorination reaction recently reported by Shibatomi et al [13], [20] This strategy applied to our domino cyclization-decarboxylative process would provide an unprecedented entry to dihydrocouramins 6 having a C3chlorinated tetrasubstituted stereocenter (Scheme 7).…”
C5-disubstituted Meldrum's acid precursors were shown to be a useful platform for the synthesis of an array of 3-alkylated dihydrocoumarins with up to 93:7 er, thanks to an enantioselective domino cyclization-decarboxylative-protonation reaction triggered by an unprecedented benzhydrylderived cupreine organocatalyst. This cyclization sequence was extended to an emerging organocatalytic decarboxylative-chlorination reaction in the presence of trichloroquinolinone and by means of a bifunctional cinchona derived Brønsted base which gave rise to the formation of dihydrocoumarins (up to 79:21 er) with a tertiary chlorinated stereocenter.Amongst the privileged coumarin scaffolds in medicinal chemistry, the dihydrocoumarin derivatives are widely distributed within naturally occurring molecules and bioactive compounds. [1] Consequently, several groups have developed catalytic enantioselective syntheses of 3,4-disubstituted chroman-2-ones [2] and, to a much lesser extent, 3,3-disubstituted homologues (Scheme 1). [3] Nevertheless, the construction of enantioenriched 3-substituted derivatives turned out to be more challenging. To the best of our knowledge, the group of Scheidt has reported the single one-step asymmetric construction of 3-substituted dihydrocoumarins upon NHC organocatalysis eliciting a (4 + 2) cycloaddition reaction with er ranging from 75:25 to 93:7. [4] Beside the elegant but two steps enamine-based approaches developed by Xie and Liu, [5a-e] requiring the final oxidation of a lactol intermediate, List and co-workers have pioneered the challenging enantiose-lective delivery of a small proton atom to ketene dithioacetals. [5f] One of the obtained product was hydrolyzed into an a-phenyl dihydrocoumarin with high enantiomeric excess. In view of this background, an expedious synthetic sequence furnishing C3-substituted dihydrocoumarin remains desirable.Very recently, the group of Guiry achieved the synthesis of a series of 3-aryl dihydrocoumarins with er ranging from 65:35 to 94:6 (Scheme 1b). [6] This functionalization strategy takes advantage of the palladium-catalyzed decarboxylative protonation reaction [7] in the presence of ephedrine as a chiral stoichiometric source of proton. Although several teams ventured into this convenient enantioselective protonation (EP) strategy, mostly from hemimalonic esters in organocatalysis, only the groups of Brunner, Rouden, Zhang and Song succeeded in getting good er (rarely > 95:5) albeit at the expense of the use of high catalyst loading (up to 1 equiv.). [8,9] Scheme 1.
“…[8,9] Scheme 1. [13] This investigation began with the phenol 1 a as a model substrate (Scheme 2, see SI for full-details). We recently introduced disubstituted Meldrum's acid (MA) derivatives as stable alternatives to hemimalonic esters for the enantioselective decarboxylative protonation reaction upon phase-transfer catalytic conditions, [10] while this architecture also affords new synthetic opportunities in heterocycle formation.…”
mentioning
confidence: 99%
“…At the onset, we considered the beautiful and unprecedented enantioselective decarboxylative chlorination reaction recently reported by Shibatomi et al [13], [20] This strategy applied to our domino cyclization-decarboxylative process would provide an unprecedented entry to dihydrocouramins 6 having a C3chlorinated tetrasubstituted stereocenter (Scheme 7). At the onset, we considered the beautiful and unprecedented enantioselective decarboxylative chlorination reaction recently reported by Shibatomi et al [13], [20] This strategy applied to our domino cyclization-decarboxylative process would provide an unprecedented entry to dihydrocouramins 6 having a C3chlorinated tetrasubstituted stereocenter (Scheme 7).…”
mentioning
confidence: 99%
“…Furthermore, by means of these MA-based platforms, a proof of concept of a sparingly reported asymmetric decarboxylative chlorination reaction was demonstrated allowing the construction of chiral C3-chlorinated dihydrocoumarins. [13] This investigation began with the phenol 1 a as a model substrate (Scheme 2, see SI for full-details). A screening of an array of chiral Brønsted bases revealed that quinine 3 a achieved the domino transformation into the desired 2 a in smooth conditions (rt, 2 hours), in a complete conversion and promising 37.5:62.5 er.…”
mentioning
confidence: 99%
“…Next, we wondered whether it could be possible to take advantage of the reactivity of the readily available Meldrum's acid platforms 4, for the construction of more substituted dihydrocoumarin derivatives. At the onset, we considered the beautiful and unprecedented enantioselective decarboxylative chlorination reaction recently reported by Shibatomi et al [13], [20] This strategy applied to our domino cyclization-decarboxylative process would provide an unprecedented entry to dihydrocouramins 6 having a C3chlorinated tetrasubstituted stereocenter (Scheme 7).…”
C5-disubstituted Meldrum's acid precursors were shown to be a useful platform for the synthesis of an array of 3-alkylated dihydrocoumarins with up to 93:7 er, thanks to an enantioselective domino cyclization-decarboxylative-protonation reaction triggered by an unprecedented benzhydrylderived cupreine organocatalyst. This cyclization sequence was extended to an emerging organocatalytic decarboxylative-chlorination reaction in the presence of trichloroquinolinone and by means of a bifunctional cinchona derived Brønsted base which gave rise to the formation of dihydrocoumarins (up to 79:21 er) with a tertiary chlorinated stereocenter.Amongst the privileged coumarin scaffolds in medicinal chemistry, the dihydrocoumarin derivatives are widely distributed within naturally occurring molecules and bioactive compounds. [1] Consequently, several groups have developed catalytic enantioselective syntheses of 3,4-disubstituted chroman-2-ones [2] and, to a much lesser extent, 3,3-disubstituted homologues (Scheme 1). [3] Nevertheless, the construction of enantioenriched 3-substituted derivatives turned out to be more challenging. To the best of our knowledge, the group of Scheidt has reported the single one-step asymmetric construction of 3-substituted dihydrocoumarins upon NHC organocatalysis eliciting a (4 + 2) cycloaddition reaction with er ranging from 75:25 to 93:7. [4] Beside the elegant but two steps enamine-based approaches developed by Xie and Liu, [5a-e] requiring the final oxidation of a lactol intermediate, List and co-workers have pioneered the challenging enantiose-lective delivery of a small proton atom to ketene dithioacetals. [5f] One of the obtained product was hydrolyzed into an a-phenyl dihydrocoumarin with high enantiomeric excess. In view of this background, an expedious synthetic sequence furnishing C3-substituted dihydrocoumarin remains desirable.Very recently, the group of Guiry achieved the synthesis of a series of 3-aryl dihydrocoumarins with er ranging from 65:35 to 94:6 (Scheme 1b). [6] This functionalization strategy takes advantage of the palladium-catalyzed decarboxylative protonation reaction [7] in the presence of ephedrine as a chiral stoichiometric source of proton. Although several teams ventured into this convenient enantioselective protonation (EP) strategy, mostly from hemimalonic esters in organocatalysis, only the groups of Brunner, Rouden, Zhang and Song succeeded in getting good er (rarely > 95:5) albeit at the expense of the use of high catalyst loading (up to 1 equiv.). [8,9] Scheme 1.
“…[10] From as ynthetic perspective,t he inherently unique reactivity of halogens can enable efficient transformations such as stereospecific S N 2s ubstitution, cross-coupling,a nd other related derivatizations. [14] However,b oth approaches generated the desired cyclic products based on a"substituent-modification" strategy starting from cycloketone substrates.A lternatively, an asymmetric cycloaddition strategy,w hich enables direct construction of halogenated cyclic structures with multiple stereocenters,has been scarcely explored, despite its inherent advantages of atom economy and potentially higher synthetic efficiency (Scheme 1B,c). Construction of ahalogenated quaternary center by enolate catalysis with cycloadditions trategy.Boc = tert-butoxycarbonyl.…”
Asymmetric construction of halogenated quaternary carbon centers under mild reaction conditions remains challenging. Reported here is an unprecedented and highly stereoselective Brønsted base catalyzed [4+2] cycloaddition between either α-chloro- or α-bromoaldehydes and cyclic enones. The key intermediate, an α-halogenated enolate, is susceptible to dehalogenation and can be stabilized and stereochemically controlled using bifunctional tertiary amines. This method provides facile access to a collection of optically pure bicyclic dihydropyrans having three contiguous stereocenters, including a halogen-bearing quaternary carbon center. Of note, the product can be transformed in situ into densely functionalized spirocyclopropanes in a highly efficient and stereoselective manner.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.